HALISTER: Glaxo 3Q Revenue, Core Operating Profit Beat Estimates

Glaxo 3Q Revenue, Core Operating Profit Beat Estimates

(Bloomberg) -- Glaxo keeps FY forecast, still sees core EPS growth of 11%-12% at constant FX.
  • 3Q rev. GBP7.54b; est. GBP7.27b
  • 3Q core operating profit GBP2.32b; est. GBP2.20b
  • Div. 19p
Link to Statement:Link
Alert: HALISTER
Source: BFW (Bloomberg First Word)

Tickers
GSK LN (GlaxoSmithKline PLC)

To de-activate this alert, click here

UUID: 7947283